From: Adrenocortical carcinosarcoma: a case report and review of the literature
Stain | Carcinomatous component | Sarcomatous component | Company | Clone | Dilution |
---|---|---|---|---|---|
AE1/AE3 | Negative | Negative | Dako | AE1/AE3 | 1:100 |
Vimentin | Positive | Positive | Ventana | V9 | Prediluted |
Desmin | Negative | Positive | Ventana | DE-R-11 | Prediluted |
Myogenin | Negative | Weakly Positive | Cell Marque | F5D | Prediluted |
Myoglobin | Negative | Positive | Ventana | Polyclonal | Prediluted |
S-100 | Negative | Negative | Dako | Polyclonal | 1:500 |
HMB-45 | Negative | Negative | Ventana | HMB45 | Prediluted |
Tyrosinase | Negative | Negative | Vector | T311 | 1:75 |
Melan-A | Focally weakly positive | focally positive | Dako | A103 | 1:100 |
Synaptophysin | Positive | focally positive | Dako | Cell Marque | Prediluted |
Chromogranin | Negative | Negative | Ventana | LIK2H10 | Prediluted |
Inhibin Alpha | Negative | Negative | Dako | R1 | 1:50 |
PLAP | Negative | Negative | Biogenex | PL8/F6 | 1:400 |
CD99 | Negative | Negative | Dako | 12E7 | 1:75 |
Calretinin | Positive | Focally positive | Invitrogen | Polyclonal | 1:100 |